Traders sold shares of Agilent Technologies Inc (NYSE:A) on strength during trading on Thursday following insider selling activity. $29.65 million flowed into the stock on the tick-up and $91.83 million flowed out of the stock on the tick-down, for a money net flow of $62.18 million out of the stock. Of all equities tracked, Agilent Technologies had the 25th highest net out-flow for the day. Agilent Technologies traded up $0.05 for the day and closed at $66.31Specifically, insider Patrick Kaltenbach sold 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 29th. The shares were sold at an average price of $67.28, for a total transaction of $269,120.00. Following the completion of the transaction, the insider now directly owns 72,547 shares of the company’s stock, valued at approximately $4,880,962.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Boon Hwee Koh sold 6,931 shares of the firm’s stock in a transaction that occurred on Tuesday, June 12th. The stock was sold at an average price of $66.38, for a total transaction of $460,079.78. The disclosure for this sale can be found here. Insiders have sold a total of 15,931 shares of company stock valued at $1,069,650 over the last three months.
Several equities analysts have recently weighed in on A shares. ValuEngine lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, May 29th. Zacks Investment Research lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Wednesday, May 16th. Cowen raised shares of Agilent Technologies from a “market perform” rating to an “outperform” rating in a report on Tuesday, May 15th. Morgan Stanley cut their target price on shares of Agilent Technologies from $95.00 to $91.00 and set an “overweight” rating for the company in a report on Wednesday, April 11th. Finally, Goldman Sachs Group raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating in a report on Monday, April 9th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $72.75.
The firm has a market capitalization of $21.16 billion, a P/E ratio of 28.10, a price-to-earnings-growth ratio of 2.31 and a beta of 1.28. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.88 and a current ratio of 3.32.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, May 14th. The medical research company reported $0.65 EPS for the quarter, topping the consensus estimate of $0.64 by $0.01. The company had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. Agilent Technologies had a net margin of 5.02% and a return on equity of 18.01%. The firm’s revenue was up 9.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.58 EPS. analysts anticipate that Agilent Technologies Inc will post 2.67 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 25th. Investors of record on Tuesday, July 3rd will be issued a $0.149 dividend. This represents a $0.60 annualized dividend and a yield of 0.90%. The ex-dividend date of this dividend is Monday, July 2nd. Agilent Technologies’s payout ratio is presently 25.42%.
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Dynamic Technology Lab Private Ltd purchased a new stake in Agilent Technologies in the 1st quarter worth $2,258,000. Chesapeake Wealth Management purchased a new stake in Agilent Technologies in the 1st quarter worth $901,000. Suntrust Banks Inc. increased its holdings in Agilent Technologies by 10.2% in the 1st quarter. Suntrust Banks Inc. now owns 18,579 shares of the medical research company’s stock worth $1,241,000 after acquiring an additional 1,713 shares in the last quarter. Polar Asset Management Partners Inc. increased its holdings in Agilent Technologies by 36.5% in the 1st quarter. Polar Asset Management Partners Inc. now owns 386,400 shares of the medical research company’s stock worth $25,850,000 after acquiring an additional 103,300 shares in the last quarter. Finally, Handelsbanken Fonder AB purchased a new stake in Agilent Technologies in the 1st quarter worth $4,883,000.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.